Alpine Immune Sciences, Inc. (NASDAQ: ALPN), is a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- orbest-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development.

Biotechnology

Health Care

Alpine Immune Sciences

Christina Yi

Stephanie Wisdo

Stanford Peng

Andrew Sandler

Kelly Mumma, SPHR (she / her)

Kristi Manjarrez

Devon Campbell

Thaedra Thullbery, CPA

Remy Durand

The Clinical and Medical Operations team at Alpine Immune Sciences is responsible for designing, executing, and overseeing clinical trials to ensure the safety and efficacy of innovative immunotherapies. Key functions include protocol development, regulatory compliance, data analysis, and liaison with key stakeholders. The team collaborates closely with R&D and external partners to translate scientific discoveries into clinical applications, with the ultimate goal of improving patient outcomes in autoimmune and inflammatory diseases.

Clinical and Medical Operations

Research and Clinical Science

Leadership Team

Clinical and Medical Operations

About

Team members

Other teams at Alpine Immune Sciences

Research and Clinical Science

Leadership Team